Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Ivermectin | Research article

Mapping lymphatic filariasis in Loa loa endemic health districts naïve for ivermectin mass administration and situated in the forested zone of Cameroon

Authors: Andrew A. Beng, Mathias E. Esum, Kebede Deribe, Abdel J. Njouendou, Patrick W. C. Ndongmo, Raphael A. Abong, Jerome Fru, Fanny F. Fombad, Gordon T. Nchanji, Glory Amambo, Narcisse T. V. Gandjui, Benjamin Biholong, Georges Nko’Ayissi, Patrick Mbia, Julie Akame, Peter I. Enyong, Steven D. Reid, Jean J. Tougoue, Yaobi Zhang, Samuel Wanji

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

The control of lymphatic filariasis (LF) caused by Wuchereria bancrofti in the Central African Region has been hampered by the presence of Loa loa due to severe adverse events that arise in the treatment with ivermectin. The immunochromatographic test (ICT) cards used for mapping LF demonstrated cross-reactivity with L. loa and posed the problem of delineating the LF map. To verify LF endemicity in forest areas of Cameroon where mass drug administration (MDA) has not been ongoing, we used the recently developed strategy that combined serology, microscopy and molecular techniques.

Methods

This study was carried out in 124 communities in 31 health districts (HDs) where L. loa is present. At least 125 persons per site were screened. Diurnal blood samples were investigated for circulating filarial antigen (CFA) by FTS and for L. loa microfilariae (mf) using TBF. FTS positive individuals were further subjected to night blood collection for detecting W. bancrofti. qPCR was used to detect DNA of the parasites.

Results

Overall, 14,446 individuals took part in this study, 233 participants tested positive with FTS in 29 HDs, with positivity rates ranging from 0.0 to 8.2%. No W. bancrofti mf was found in the night blood of any individuals but L. loa mf were found in both day and night blood of participants who were FTS positive. Also, qPCR revealed that no W. bancrofti but L.loa DNA was found with dry bloodspot. Positive FTS results were strongly associated with high L. loa mf load. Similarly, a strong positive association was observed between FTS positivity and L loa prevalence.

Conclusions

Using a combination of parasitological and molecular tools, we were unable to find evidence of W. bancrofti presence in the 31 HDs, but L. loa instead. Therefore, LF is not endemic and LF MDA is not required in these districts.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bakajika DK, Nigo MM, Lotsima JP, Masikini GA, Fischer K, Lloyd MM, Weil GJ, Fischer PU. Filarial antigenemia and Loa loa night blood microfilaremia in an area without bancroftian filariasis in the Democratic Republic of Congo. Am J Trop Med Hyg. 2014;91(6):1142–8.CrossRef Bakajika DK, Nigo MM, Lotsima JP, Masikini GA, Fischer K, Lloyd MM, Weil GJ, Fischer PU. Filarial antigenemia and Loa loa night blood microfilaremia in an area without bancroftian filariasis in the Democratic Republic of Congo. Am J Trop Med Hyg. 2014;91(6):1142–8.CrossRef
2.
go back to reference Boussinesq M. La filariose lymphatique au Cameroun: état des connaissances. , . In., vol. 32. Bulletin de Liaison et de Documentation-OCEAC; 1999: 7–12. Boussinesq M. La filariose lymphatique au Cameroun: état des connaissances. , . In., vol. 32. Bulletin de Liaison et de Documentation-OCEAC; 1999: 7–12.
3.
go back to reference Boussinesq M, Kamgno J, S. P. Treatment of Loa patients: pre- and post- treatment loamicrofilarial levels and SAEs—experience in Cameroon. In., vol. 63rd annual meeting. Sheraton New Orleans Hotel, New Orleans, LA USA: ASTMH; 2014. Boussinesq M, Kamgno J, S. P. Treatment of Loa patients: pre- and post- treatment loamicrofilarial levels and SAEs—experience in Cameroon. In., vol. 63rd annual meeting. Sheraton New Orleans Hotel, New Orleans, LA USA: ASTMH; 2014.
4.
go back to reference WHO: Lymphatic filariasis. World Health Organization Fact Sheet 102. 2014. WHO: Lymphatic filariasis. World Health Organization Fact Sheet 102. 2014.
5.
go back to reference WHO: Lymphatic filariasis. World Health Organization Fact Sheet of 2nd March 2020. In.; 2020. WHO: Lymphatic filariasis. World Health Organization Fact Sheet of 2nd March 2020. In.; 2020.
6.
go back to reference Michael E, Malecela-Lazaro MN, Kabali C, Snow LC, Kazura JW. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions. Trends Parasitol. 2006;22(5):226–33.CrossRef Michael E, Malecela-Lazaro MN, Kabali C, Snow LC, Kazura JW. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions. Trends Parasitol. 2006;22(5):226–33.CrossRef
7.
go back to reference WHO: World Health Organization: Global programme to eliminate lymphatic filariasis: progress report, 2011. In., vol. 87. Weekly Epidemiol Rec, ; 2012: 346–356. WHO: World Health Organization: Global programme to eliminate lymphatic filariasis: progress report, 2011. In., vol. 87. Weekly Epidemiol Rec, ; 2012: 346–356.
8.
go back to reference Nana-Djeunga HC, Tchatchueng-Mbougua JB, Bopda J, Mbickmen-Tchana S, Elong-Kana N, Nnomzo'o E, Akame J, Tarini A, Zhang Y, Njiokou F, et al. Mapping of Bancroftian Filariasis in Cameroon: prospects for elimination. PLoS Negl Trop Dis. 2015;9(9):e0004001.CrossRef Nana-Djeunga HC, Tchatchueng-Mbougua JB, Bopda J, Mbickmen-Tchana S, Elong-Kana N, Nnomzo'o E, Akame J, Tarini A, Zhang Y, Njiokou F, et al. Mapping of Bancroftian Filariasis in Cameroon: prospects for elimination. PLoS Negl Trop Dis. 2015;9(9):e0004001.CrossRef
9.
go back to reference Nana-Djeunga HC, Tchouakui M, Njitchouang GR, Tchatchueng-Mbougua JB, Nwane P, Domche A, Bopda J, Mbickmen-Tchana S, Akame J, Tarini A, et al. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination. PLoS Negl Trop Dis. 2017;11(6):e0005633.CrossRef Nana-Djeunga HC, Tchouakui M, Njitchouang GR, Tchatchueng-Mbougua JB, Nwane P, Domche A, Bopda J, Mbickmen-Tchana S, Akame J, Tarini A, et al. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination. PLoS Negl Trop Dis. 2017;11(6):e0005633.CrossRef
10.
go back to reference Esum M, Wanji S, Tendongfor N, Enyong P. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin. Trans R Soc Trop Med Hyg. 2001;95(6):673–6.CrossRef Esum M, Wanji S, Tendongfor N, Enyong P. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin. Trans R Soc Trop Med Hyg. 2001;95(6):673–6.CrossRef
11.
go back to reference Molyneux DH, Hopkins A, Bradley MH, Kelly-Hope LA. Multidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of worms. Parasit Vectors. 2014;7:363.CrossRef Molyneux DH, Hopkins A, Bradley MH, Kelly-Hope LA. Multidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of worms. Parasit Vectors. 2014;7:363.CrossRef
12.
go back to reference Kelly-Hope LA, Hemingway J, Taylor MJ, Molyneux DH. Increasing evidence of low lymphatic filariasis prevalence in high risk Loa loa areas in central and West Africa: a literature review. Parasit Vectors. 2018;11(1):349.CrossRef Kelly-Hope LA, Hemingway J, Taylor MJ, Molyneux DH. Increasing evidence of low lymphatic filariasis prevalence in high risk Loa loa areas in central and West Africa: a literature review. Parasit Vectors. 2018;11(1):349.CrossRef
13.
go back to reference Wanji S, Kengne-Ouafo JA, Esum ME, Chounna PW, Tendongfor N, Adzemye BF, Eyong JE, Jato I, Datchoua-Poutcheu FR, Kah E, et al. Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment. Parasit Vectors. 2015;8:202.CrossRef Wanji S, Kengne-Ouafo JA, Esum ME, Chounna PW, Tendongfor N, Adzemye BF, Eyong JE, Jato I, Datchoua-Poutcheu FR, Kah E, et al. Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment. Parasit Vectors. 2015;8:202.CrossRef
14.
go back to reference Wanji S, Amvongo-Adjia N, Njouendou AJ, Kengne-Ouafo JA, Ndongmo WP, Fombad FF, Koudou B, Enyong PA, Bockarie M. Further evidence of the cross-reactivity of the Binax NOW(R) Filariasis ICT cards to non-Wuchereria bancrofti filariae: experimental studies with Loa loa and Onchocerca ochengi. Parasit Vectors. 2016;9:267.CrossRef Wanji S, Amvongo-Adjia N, Njouendou AJ, Kengne-Ouafo JA, Ndongmo WP, Fombad FF, Koudou B, Enyong PA, Bockarie M. Further evidence of the cross-reactivity of the Binax NOW(R) Filariasis ICT cards to non-Wuchereria bancrofti filariae: experimental studies with Loa loa and Onchocerca ochengi. Parasit Vectors. 2016;9:267.CrossRef
15.
go back to reference Pion SD, Montavon C, Chesnais CB, Kamgno J, Wanji S, Klion AD, Nutman TB, Boussinesq M. Positivity of antigen tests used for diagnosis of lymphatic Filariasis in individuals without Wuchereria bancrofti infection but with high Loa loa Microfilaremia. Am J Trop Med Hyg. 2016;95(6):1417–23.CrossRef Pion SD, Montavon C, Chesnais CB, Kamgno J, Wanji S, Klion AD, Nutman TB, Boussinesq M. Positivity of antigen tests used for diagnosis of lymphatic Filariasis in individuals without Wuchereria bancrofti infection but with high Loa loa Microfilaremia. Am J Trop Med Hyg. 2016;95(6):1417–23.CrossRef
16.
go back to reference Weil GJ, Curtis KC, Fakoli L, Fischer K, Gankpala L, Lammie PJ, Majewski AC, Pelletreau S, Won KY, Bolay FK, et al. Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood. Am J Trop Med Hyg. 2013;89(1):11–5.CrossRef Weil GJ, Curtis KC, Fakoli L, Fischer K, Gankpala L, Lammie PJ, Majewski AC, Pelletreau S, Won KY, Bolay FK, et al. Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood. Am J Trop Med Hyg. 2013;89(1):11–5.CrossRef
17.
go back to reference Wanji S, Esum ME, Njouendou AJ, Mbeng AA, Chounna Ndongmo PW, Abong RA, Fru J, Fombad FF, Nchanji GT, Ngongeh G, et al. Mapping of lymphatic filariasis in loiasis areas: a new strategy shows no evidence for Wuchereria bancrofti endemicity in Cameroon. PLoS Negl Trop Dis. 2019;13(3):e0007192.CrossRef Wanji S, Esum ME, Njouendou AJ, Mbeng AA, Chounna Ndongmo PW, Abong RA, Fru J, Fombad FF, Nchanji GT, Ngongeh G, et al. Mapping of lymphatic filariasis in loiasis areas: a new strategy shows no evidence for Wuchereria bancrofti endemicity in Cameroon. PLoS Negl Trop Dis. 2019;13(3):e0007192.CrossRef
18.
go back to reference Rao RU, Atkinson LJ, Ramzy RM, Helmy H, Farid HA, Bockarie MJ, Susapu M, Laney SJ, Williams SA, Weil GJ. A real-time PCR-based assay for detection of Wuchereria bancrofti DNA in blood and mosquitoes. Am J Trop Med Hyg. 2006;74(5):826–32.CrossRef Rao RU, Atkinson LJ, Ramzy RM, Helmy H, Farid HA, Bockarie MJ, Susapu M, Laney SJ, Williams SA, Weil GJ. A real-time PCR-based assay for detection of Wuchereria bancrofti DNA in blood and mosquitoes. Am J Trop Med Hyg. 2006;74(5):826–32.CrossRef
19.
go back to reference Fink DL, Kamgno J, Nutman TB. Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia. PLoS Negl Trop Dis. 2011;5(8):e1299.CrossRef Fink DL, Kamgno J, Nutman TB. Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia. PLoS Negl Trop Dis. 2011;5(8):e1299.CrossRef
20.
go back to reference Natural Earth: Natural Earth. Available at https://www.naturalearthdata.com/. Accessed 02 Novemebr ,2019.. Natural Earth: Natural Earth. Available at https://​www.​naturalearthdata​.​com/​.​ Accessed 02 Novemebr ,2019..
21.
go back to reference Yahathugoda TC, Supali T, Rao RU, Djuardi Y, Stefani D, Pical F, Fischer PU, Lloyd MM, Premaratne PH, Weerasooriya MV, et al. A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration. Parasit Vectors. 2015;8:369.CrossRef Yahathugoda TC, Supali T, Rao RU, Djuardi Y, Stefani D, Pical F, Fischer PU, Lloyd MM, Premaratne PH, Weerasooriya MV, et al. A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration. Parasit Vectors. 2015;8:369.CrossRef
22.
go back to reference More SJ, Copeman DB. A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis. Trop Med Parasitol. 1990;41(4):403–6.PubMed More SJ, Copeman DB. A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis. Trop Med Parasitol. 1990;41(4):403–6.PubMed
23.
go back to reference Pion SD, Montavon C, Chesnais CJ, Kamgno J, Wanji. S ea. Correlation between high Loa loa microfilaremia and levels of circulating filarial antigens used to detect Wuchereriabancrofti infection. In: 63rd Annual Meeting, TropMed14. Sheraton New Hotel NewOrleans LAUSA: ASTMH; 2014: pp. 377. Pion SD, Montavon C, Chesnais CJ, Kamgno J, Wanji. S ea. Correlation between high Loa loa microfilaremia and levels of circulating filarial antigens used to detect Wuchereriabancrofti infection. In: 63rd Annual Meeting, TropMed14. Sheraton New Hotel NewOrleans LAUSA: ASTMH; 2014: pp. 377.
24.
go back to reference Thomson MC, Obsomer V, Kamgno J, Gardon J, Wanji S, Takougang I, Enyong P, Remme JH, Molyneux DH, Boussinesq M. Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis control. Filaria J. 2004;3(1):7.CrossRef Thomson MC, Obsomer V, Kamgno J, Gardon J, Wanji S, Takougang I, Enyong P, Remme JH, Molyneux DH, Boussinesq M. Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis control. Filaria J. 2004;3(1):7.CrossRef
25.
go back to reference Deribe K, Beng AA, Cano J, Njouendo AJ, Fru-Cho J, Awah AR, Eyong ME, Chounna Ndongmo PW, Giorgi E, Pigott DM, et al. Mapping the geographical distribution of podoconiosis in Cameroon using parasitological, serological, and clinical evidence to exclude other causes of lymphedema. PLoS Negl Trop Dis. 2018;12(1):e0006126.CrossRef Deribe K, Beng AA, Cano J, Njouendo AJ, Fru-Cho J, Awah AR, Eyong ME, Chounna Ndongmo PW, Giorgi E, Pigott DM, et al. Mapping the geographical distribution of podoconiosis in Cameroon using parasitological, serological, and clinical evidence to exclude other causes of lymphedema. PLoS Negl Trop Dis. 2018;12(1):e0006126.CrossRef
26.
go back to reference Weil GJ, Ramzy RM. Diagnostic tools for filariasis elimination programs. Trends Parasitol. 2007;23(2):78–82.CrossRef Weil GJ, Ramzy RM. Diagnostic tools for filariasis elimination programs. Trends Parasitol. 2007;23(2):78–82.CrossRef
27.
go back to reference Ottesen EA, Duke BO, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ. 1997;75(6):491–503.PubMedPubMedCentral Ottesen EA, Duke BO, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ. 1997;75(6):491–503.PubMedPubMedCentral
Metadata
Title
Mapping lymphatic filariasis in Loa loa endemic health districts naïve for ivermectin mass administration and situated in the forested zone of Cameroon
Authors
Andrew A. Beng
Mathias E. Esum
Kebede Deribe
Abdel J. Njouendou
Patrick W. C. Ndongmo
Raphael A. Abong
Jerome Fru
Fanny F. Fombad
Gordon T. Nchanji
Glory Amambo
Narcisse T. V. Gandjui
Benjamin Biholong
Georges Nko’Ayissi
Patrick Mbia
Julie Akame
Peter I. Enyong
Steven D. Reid
Jean J. Tougoue
Yaobi Zhang
Samuel Wanji
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Ivermectin
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05009-3

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue